Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2250 (LINC02250) is a human gene encoding a long non-coding RNA located on chromosome 15 (hg38: chr15:25484831-25578797, reverse strand). It is officially described and cataloged under multiple identifiers: LINC02250 (HGNC), ENSG00000235731 (Ensembl), and the alias TCONS_00023273. As an lncRNA, it does not encode a protein product. There is currently no scientific literature indicating a well-defined biological function, mechanism, or direct implication in disease states, nor is it recognized as a marker or a clinical therapeutic target. It is currently classified solely as a non-coding RNA gene, consistent with many other lncRNAs whose functions may remain to be elucidated.
Not applicable, as no drugs or therapeutic interventions target this RNA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2250 (LINC02250).